Market Performance
Indian equity benchmarks ended Wednesday's session on a subdued note, extending a corrective phase. The Nifty50 opened lower and remained under pressure for most of the day, ultimately closing at 26,140.75, a marginal dip of approximately 0.14%. Sectoral performance was varied, with information technology and pharmaceutical stocks showing relative strength. Conversely, automobile and real estate counters experienced selling pressure. Notably, broader indices outpaced the benchmark, gaining around 0.5% each, indicating selective participation beyond frontline counters.
Analyst Outlook
Market sentiment was influenced by mixed global cues and persistent geopolitical concerns, which tempered risk appetite. Rotational selling in select index heavyweights like ITC, HDFC Bank, and Reliance Industries also constrained upside potential and limited an broader uptrend. In the absence of strong domestic catalysts, trading activity remained largely stock-specific, with participants adopting a cautious stance ahead of upcoming corporate earnings and key macroeconomic data releases. Technically, the Nifty has approached its initial support level, the 20-day daily exponential moving average (DEMA). Near-term support is anticipated in the 26,000-26,100 zone, with a more substantial base expected around 25,800.
Stock Recommendations
Ajit Mishra, Senior Vice President – Research at Religare Broking, advised investors to focus on stock-specific opportunities and utilize market dips to gradually accumulate quality names within outperforming sectors. Mishra highlighted three stocks with strong technical setups:
BSE Limited
BSE Limited (LTP: ₹2,744.90) presents a structurally sound technical foundation, with its price sustained above a rising long-term moving average, affirming a bullish primary trend. The stock recently broke out of a descending consolidation pattern that followed a corrective phase, suggesting orderly profit-taking rather than a trend reversal. A decisive rebound from a well-defined support zone, backed by healthy volumes, signals strong accumulation. Initiating long positions at current levels offers a favorable risk-reward profile, with a target set at ₹2,920 and a stop-loss at ₹2,650.
HCL Technologies Limited
HCL Technologies Limited (LTP: ₹1,647.70) is demonstrating renewed momentum, moving in line with the broader IT sector trend. After emerging from a corrective phase, the stock has shown resilience, maintaining its position above the 200-day exponential moving average (EMA). The formation of a fresh pivot point, coupled with a small-range breakout, indicates a continuation of positive momentum. A supportive sectoral backdrop and stable chart structure present a renewed buying opportunity for traders. The target is ₹1,760, with a stop-loss at ₹1,590.
Lupin Limited
Lupin Limited (LTP: ₹2,214.30) is showing relative outperformance within the pharmaceutical sector, which is attempting a strong breakout after over a year in a corrective phase. Lupin has completed its correction, marked by a decisive breakout from a prolonged consolidation phase, signaling the commencement of a new upward trajectory. Traders are advised to accumulate the stock while strictly adhering to the specified target of ₹2,360 and a stop-loss of ₹2,130.